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Abstract
Background: Innovative ways of delivering care are needed to improve outcomes for older people with multimorbidity.
Health coaching involves ‘a regular series of phone calls between patient and health professional to provide support and
encouragement to promote healthy behaviours’. This intervention is promising, but evidence is insufficient to support a
wider role in multimorbidity care. We evaluated health coaching in older people with multimorbidity.
Methods: We used the innovative ‘Trials within Cohorts’ design. A cohort was recruited, and a trial was conducted using a
‘patient-centred’ consent model. A randomly selected group within the cohort were offered the intervention and were
analysed as the intervention group whether they accepted the offer or not.
The intervention sought to improve the skills of patients with multimorbidity to deal with a range of long-term conditions,
through health coaching, social prescribing and low-intensity support for low mood.
Results: We recruited 4377 older people, and 1306 met the eligibility criteria (two or more long-term conditions
and moderate ‘patient activation’). We selected 504 for health coaching, and 41% consented. More than 80% of
consenters received the defined ‘dose’ of 4+ sessions.
In an intention-to-treat analysis, those selected for health coaching did not improve on any outcome (patient activation,
quality of life, depression or self-care) compared to usual care.
We examined health care utilisation using hospital administrative and self-report data. Patients selected for health
coaching demonstrated lower levels of emergency care use, but an increase in the use of planned services and
higher overall costs, as well as a quality-adjusted life year (QALY) gain. The incremental cost per QALY was £8049,
with a 70–79% probability of being cost-effective at conventional levels of willingness to pay.
Conclusions: Health coaching did not lead to significant benefits on the primary measures of patient-reported
outcome. This is likely related to relatively low levels of uptake amongst those selected for the intervention.
Demonstrating effectiveness in this design is challenging, as it estimates the effect of being selected for treatment, regardless
of whether treatment is adopted. We argue that the treatment effect estimated is appropriate for health coaching, a proactive
model relevant to many patients in the community, not just those seeking care.
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Background
Multimorbidity, defined as ‘the co-existence of two or
more chronic conditions, where one is not necessarily
more central than the others’ [1], is highly prevalent [2].
Patients with multimorbidity are a major focus of health
systems, but they face barriers to accessing high-quality
care [3–5], and they incur high costs [6]. Recently, clinical
guidelines for multimorbidity have highlighted the need
for innovative models of care [7]. Successful self-
management will be crucial for improving the health out-
comes of patients with multimorbidity, but the current
evidence for effectively managing multimorbidity is weak.
A recent Cochrane review reported only 18 trials [8], with
some evidence for interventions targeted at risk factors
such as depression or specific functional difficulties. The
review concluded that there is an urgent need for inter-
ventions that can help patients with multimorbidity to
better self-manage their conditions to prevent exacerba-
tions and avoid expensive care utilisation [9].
For self-management to be cost-effective at a population
level, interventions must be delivered to a significant pro-
portion of the population in need, not just those moti-
vated to participate. This is described as ‘reach’ [10].
Evidence of reach is often lacking in trials of self-
management, because only a proportion of those meeting
the eligibility criteria actually participate [11]. Evidence of
reach can be particularly problematic amongst people
with multimorbidity because they are often excluded from
trials [12]. This study aimed to evaluate the impact of an
intervention that can be used with a large number of
patients, using a trial design that can better assess the
likely population benefit of the intervention.
The ‘trial within a cohort’ as a test of intervention ‘reach’
In a conventional trial, participants receive information,
then provide consent to participate and are randomised.
Critically, patients are told about the different treat-
ments available, but only half are randomised to each.
Patients with preferences for one treatment may be less
likely to take part [13].
The ‘Trials within Cohorts’ (TWiCs) design more
closely mimics the way treatment decisions are made in
routine care [14]. A cohort of participants are recruited
and followed up systematically. Under the form of
TWiCs used here, all eligible participants in the cohort
are identified, and a sample is selected at random.
Patients selected for the intervention are contacted and
offered the treatment, which they can either decide to
receive — and provide informed consent — or decline.
Whether or not a patient consents to treatment, for the
purposes of this design, they remain part of the interven-
tion arm. All those eligible but not selected are not con-
tacted for participation and become controls.
The TWiCs design has two potential advantages. It
more closely mimics the process of treatment decision-
making in routine care, as patients are offered a treat-
ment (which they can decline) rather than being offered
two treatments, then allocated at chance. The design
also provides a different (and in some contexts more
useful) estimate of the effects of the offer of treatment
amongst all those who are eligible, rather than amongst
a subset who agree to receive the treatment. As such, it
may have greater relevance for treatments designed to
have broad ‘reach’ amongst the wider population. Exam-
ples would include diabetes prevention programmes [15]
and self-management programmes for older people with
long-term conditions [16, 17].
Health coaching as a population health intervention
Self-management is critical for patients with long-term
conditions. A model that has received significant atten-
tion is health coaching, defined as ‘a regular series of
phone calls between patient and health professional...to
provide support and encouragement to the patient, and
promote healthy behaviours such as treatment control,
healthy diet, physical activity and mobility, rehabilitation,
and good mental health’ [18].
Various types of health coaching exist that differ in
content, delivery (face to face, remote), and personnel.
An important issue is whom is targeted for health
coaching. It can be provided for patients predicted to be
high users of services or following events such as hos-
pital discharge [19]. Although the rationale for such
targeting is clear, many patients identified as high users
of care revert to lower patterns over time without inter-
vention [20]. There may be an argument for broader
strategies targeting the wider population of patients who
are currently well but whose current self-management is
not optimal. These patients can be described as being
less ‘activated’. Patient activation is defined as how well
a patient understands his/her own role in personal
health care, reflecting knowledge, skills and confidence
[21, 22]. Activation may be a method of targeting coach-
ing to maximise benefit. Another important factor may
be depression, which is associated with poor outcomes
in multimorbidity and may be important in self-
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management [23]. Treatment burden is an additional
factor of relevance in this patient population. It is
defined as ‘the impact of the “work of being a patient”
on functioning and well-being’ [24, 25] and occurs when
the tasks of managing multiple conditions become a det-
riment to health and well-being.
An increasing number of systematic reviews have been
published on the effectiveness of health coaching. Most
suggest significant, modest short-term benefits, and
some also support longer term gains [26–33]. However,
it is difficult to generalise these findings to care for
people with multimorbidity, as many trials are focussed
on people with only one long-term condition [28, 32].
Further research is indicated to examine the impact of
health coaching, assessing reach and the cost-
effectiveness of this intervention amongst patients with
multimorbidity.
Methods
Study design and participants
The study was embedded in a wider integrated care
programme to improve care for older people with long-
term conditions in North West England. The CLASSIC
study is a longitudinal cohort study evaluating this inte-
grated care programme. Embedded within CLASSIC, the
Proactive Telephone Coaching and Tailored Support
(PROTECTS) trial used the TWiCs design to assess the
cost-effectiveness of health coaching for patients with
multimorbidity. PROTECTS is reported as per Consoli-
dated Standards of Reporting Trials (CONSORT) guide-
lines (see Additional file 1: CONSORT checklist). The
trial protocol is also included as an additional file
(Additional file 2).
The integrated care programme was delivered to pa-
tients over the age of 65 with at least one long-term
condition, and we recruited these patients to the
CLASSIC cohort [34]. FARSITE is a software package
(http://nweh.co.uk/products/farsite) that enables cen-
tralised searching of general practitioner (GP) records.
FARSITE was used to generate a list of eligible
patients in each practice, and the results were pro-
vided to general practices to allow them to remove
any patients meeting the exclusion criteria (patients
in palliative care or with reduced capacity to consent)
prior to asking them for consent. A total of 12,989
patients were eligible between November 2014 and
February 2015. If they did not respond, they were
sent a reminder 3 weeks later. Participants were of-
fered an incentive of a £10 voucher. At baseline, 4377
people (34.2%) returned a questionnaire. We did not
have access to data on non-respondents.
For inclusion in PROTECTS, patients had to have 2 or
more self-reported long-term conditions from a list of
15 [35], and must have been assessed as needing some
assistance with self-management, defined via scores on
the Patient Activation Measure (PAM) [36]. The PAM
allows activation to be categorised into four levels. Level
1 includes passive recipients of care, level 2 includes
those who lack the basic knowledge and confidence to
self-manage, level 3 is those who have the basic know-
ledge but lack the confidence and skills to engage in
self-management and level 4 is those who have the
knowledge, confidence and skills and may only require
support during times of stress [36]. We included patients
in PROTECTS whose scores placed them in level 2 or 3
of activation, because these patients showed some evi-
dence of self-management which could be improved by
health coaching.
Randomisation and masking
As noted earlier, patients eligible for the trial are identi-
fied from the cohort and randomly selected for treat-
ment. We piloted these procedures in 50 patients to test
the rate of uptake of the new treatment. After assess-
ment of eligibility, we selected patients to be offered
health coaching at random, using appropriate central
randomisation through a clinical trials unit to ensure
concealment of allocation. In this pragmatic evaluation,
we did not blind either patients or providers.
Procedures
The intervention was health coaching, as defined earlier.
The content of the health coaching was based on three
core mechanisms:
1. Telephone health coaching involved support and
encouragement to the patient to promote healthy
behaviours around diet, exercise, smoking and
alcohol, through provision of information and
motivation for long-term conditions. The core
health coaching materials include telephone and as-
sociated patient tracking and management software,
and health coaching scripts for lifestyle support.
2. Social prescribing involved links to resources in the
wider community through the community and
voluntary sector [37, 38]. Access to local resources
was provided through either PLANS
(http://www.plansforyourhealth.org/, a self-
assessment tool for users to assess their health and
social needs, with links to relevant community re-
sources and local support) or the Ways to Well-
being site (on-line resources and information, no
longer available in the form used in the trial).
3. Low-intensity support for low mood included
assessment of common mental health problems,
simple lifestyle advice and behavioural techniques
to manage mood, and use of appropriate risk
assessment protocols [39, 40].
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Six monthly phone calls to participants were planned.
The receipt of four out of the six planned calls was con-
sidered a complete ‘dose’ of the intervention.
The PROTECTS intervention was delivered by a
‘health advisor’ (a National Health Service (NHS)
Agenda for Change Band 4 worker) with skills in infor-
mation technology and communication, as well as
experience in working with the general public. Advisors
already had experience with coaching for diabetes and
use of social prescribing. The health advisor attended
3 days of training specific to working with low mood.
They were given a manual which outlined the key ele-
ments of the low-intensity intervention used (behav-
ioural activation, cognitive restructuring, problem
solving). They also received monthly group clinical
supervision which focussed on working with low mood.
The health advisor were further supported by a special-
ist nurse manager and received additional advice on
mental health and social prescribing (i.e. referral to rele-
vant community resources) from the research team.
Patients routinely had continuity in their coach for the
duration of their treatment. There were no formal links
with primary care as part of the intervention. The health
coaching was delivered via telephone from a central
NHS facility. Proactive, monthly calls of around 20 min
were made for a period of 6 months, with the option for
additional calls to deal with complex patients or issues
of risk. Health coaching staff were trained to customize
calls to the individual patient. Provision of support for
low mood and social prescribing were made where
appropriate.
The design meant that the comparator for patients
meeting the eligibility criteria who were not selected for
the intervention was usual NHS care. We collected de-
tails of that care for the economic evaluation.
Outcomes
PROTECTS was nested within the CLASSIC cohort,
which used a wide range of measures, varying at differ-
ent time points. A pre-specified subgroup of primary
outcomes were used in PROTECTS. All outcomes were
collected via postal survey at four time points across the
study: at baseline, then at 6, 12 and 20 months. The
protocol was registered and updated in a registry
(ISRCTN 12286422).
The primary outcome measures were:
- Self-management. The PAM is a self-report measure
of patient knowledge, skills and confidence in self-
management for long-term conditions [22, 36, 41].
We used the short 13-item version. The score is
categorised into four levels for eligibility determination,
although we used the continuous score in the analyses.
- Quality of life. The World Health Organization
Quality of Life brief measure (WHOQOL-BREF) is a
26-item measure of global quality of life (QOL), which
has been validated in a large international population
with physical and mental long-term conditions. QOL is
measured across four domains: physical, psychological,
social and environmental, as well as a single-item scale
for QOL [42]. We used the physical domain score as
the most relevant in relation to the PROTECTS
intervention.
Secondary outcome measures were:
- Depression. The Mental Health Inventory (MHI-5) is
a 5-item scale which measures general mental health
[43]. This measure is well validated for identifying de-
pression symptoms, with a higher score indicating bet-
ter mental health [44, 45]. The recommended cutoff
score of 60 was used to indicate the presence of ‘prob-
able depression’ [45], although we used the continuous
score in the analyses.
- Self-care. The Summary of Diabetes Self-Care Activ-
ities (SDSCA) is a 7-item measure assessing the num-
ber of days per week respondents engage in healthy and
unhealthy behaviours (i.e. eating fruits and vegetables,
eating red meat, undertaking exercise, drinking alcohol
and smoking) [46].
Power and statistical analysis
At the time of study development, there were no be-
spoke methods for powering this TWiCs design, and we
used conventional methods [47]. We powered the study
to have 80% power (alpha 5%) to detect a standardised
effect size of 0.25 on any continuous outcome measure.
Allowing for 25% attrition amongst participants — and
assuming that outcome measures at baseline correlate 0.
5 with their respective follow-ups — 504 patients were
indicated, with 252 randomised to treatment. The
CLASSIC cohort included 1306 patients eligible for
PROTECTS, and we randomly selected 252 to be offered
the intervention. The uptake rate was lower than antici-
pated, and we therefore offered the intervention to a fur-
ther 252 patients. This resulted in a final intervention
group of 504 of which 207 consented to the interven-
tion, with the remaining 802 as controls. However, under
the TWiCs framework, all 504 patients offered treatment
remain in the treatment group in analysis, including
those who declined. In consequence, the eventual effect
size detectable at 80% power was 0.39 amongst the sub-
sample consenting to treatment.
The analysis followed intention-to-treat principles and
a pre-specified analysis plan. In summary, we report the
trial and analysis according to updated CONSORT stan-
dards and utilising the extension for pragmatic trials
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[48]. The main hypothesis test of the intervention was
that the overall effect of the intervention is zero. The
primary analysis used complete cases only. Condition
group was used as a binary variable. All outcomes were
treated as though continuous and normally distributed
(in all cases both skewness and kurtosis were < =1.0) and
analysed using linear multiple regression. Baseline values
of outcomes and a set of pre-specified covariates consid-
ered prognostic of outcome were included in all ana-
lyses: gender, age (categorised as 65–69, 0–79, 80–98),
health literacy [49], social support [50], patient activa-
tion, depression and quality of life (physical health
domain). Robust estimates of variance were used ac-
counting for the clustering of patients within practices.
We ran two sensitivity analyses. The first repeated the
primary analyses using multiple imputation to include
cases with missing baseline or follow-up data. Missing
data values were imputed using chained-equation mul-
tiple imputation and scores on all available outcome
measures and patient demographics at baseline and
follow-up. Twenty multiple imputation sets were used to
ensure stability of results. The second sensitivity analysis
assessed the robustness of the primary analysis results to
removal of the pre-specified covariates from the model
(not including the outcome at baseline).
Health coaching in the trial was delivered by an exist-
ing service managing other patients outside the trial,
rather than a bespoke service. This, combined with the
time taken to administer and analyse the cohort and
randomly select the groups, meant that no patient was
offered treatment until 6 months after the baseline
assessment for the CLASSIC cohort, and for some the
offer was not made until month 12 or later. This caused
variations in the duration of time before start of the
treatment (range 259 to 513 days after baseline assess-
ment). Length of follow-up from end of treatment to
20 months follow-up was similarly variable. Thus, the
trial is considered to have run over 20 months, with pa-
tients receiving treatment at any time after the initial
6 months. As these implementation delays were not
anticipated, the pre-specified analysis plan stated that
the primary analysis would assess the change in out-
comes between baseline and 20 months follow-up.
The design provides an estimate of the mean effect in
people offered treatment. Compared to a pragmatic trial,
which provides an estimate of the mean effect in people
agreeing to treatment, the effect is ‘diluted’ by the pro-
portion of patients in the treatment arm who do not
consent to treatment. An estimate of the treatment ef-
fect in those patients consenting to treatment was
derived through application of a complier average causal
effect (CACE) analysis [51, 52]. The CACE estimator
was obtained by dividing the mean effect estimate by the
proportion giving consent [51]. The CACE estimate is
typically larger, but the power to detect an effect is not
greater, since the variance of the estimate increases pro-
portionately [53].
Cost-effectiveness analysis
The primary outcome measure for the economic
evaluation was the EuroQOL 5-Dimension 5-Level
(EQ-5D-5L) [54], a generic measure of health-related
QOL covering five domains (mobility, self-care, usual
activities, pain/discomfort, anxiety/depression). This
new version was developed due to concerns over the
lack of sensitivity to change of the original scale, and
consists of five severity levels for each domain.
Published English general population preference
weightings were used to convert responses to a single
utility index [55].
The perspective of the economic analysis was that of
the English NHS. Individual patient-level health care
resource utilisation over the trial period was collected
from two sources. The number of GP contacts in the
previous 6 months was collected from self-report data at
6-monthly intervals. Hospital utilisation was extracted
from linked administrative patient records provided by
the NHS, divided into emergency admissions (short
stays ≤5, long stays > 5 days), elective admissions, elect-
ive day cases, outpatient attendances and accident and
emergency (A&E) department attendances.
The economic analysis assessed the incremental cost-
effectiveness of the offer of health coaching compared
with usual care from the perspective of the NHS. EQ-
5D-5L data were combined with in-hospital mortality
information from the secondary care utilisation data,
applying a utility value of 0 upon death. Quality-
adjusted life years (QALYs) were calculated using the
area under the curve method assuming linear extrapo-
lation of utility between time points. QALYs in the
second year of the trial were discounted at an annual
rate of 3.5% as specified by NICE [56].
Intervention costs were estimated combining the cost
of training and supervision, written materials and deliv-
ery of the health coaching sessions. The intervention
was offered to all participants selected, although only
189 received at least one call. Only patients receiving at
least one call were assigned treatment costs, and the
intervention costs were therefore estimated based on
these 189 participants.
Patient-level resource utilisation data were combined
with relevant unit cost data for the price year 2014–
2015 to calculate total costs. Unit costs not available for
this price year were inflated to 2014/2015 prices using
the consumer price index [57]. Costs occurring in the
second year were discounted at a rate of 3.5% [56]. Unit
cost figures were sourced from the Personal Social
Panagioti et al. BMC Medicine  (2018) 16:80 Page 5 of 15
Services Research Unit’s unit costs of Health and Social
Care 2015 and national NHS Reference Costs [58, 59].
Follow-up questionnaire completion dates were
missing in a small number of cases (n = 2). In these
instances, dates were imputed using the mean length
of time between baseline and follow-up for the sam-
ple for the purpose of QALY and cost calculations.
Missing information on age and gender were sourced
from the linked hospital administrative data, where
available (gender n = 6, age n = 35). For the remaining
individuals with missing age (n = 30) or missing base-
line EQ-5D-5L (n = 29), mean imputation was used to
ensure independence from treatment allocation [60].
For missing EQ-5D-5L and resource use data, we
used multiple imputation by chained equations (ICE)
to generate 50 imputed datasets assuming the data
were missing at random. The independent variables
specified in the imputation models were age, gender,
treatment arm and baseline EQ-5D-5L. To account
for non-normality, predictive mean matching was
used which forces imputations to only take values
observed in the original dataset. Multiple imputation
(MI) was conducted using Stata’s ICE package, and
analysis using Stata’s MI package.
The incremental cost-effectiveness ratio (ICER) was
calculated, adjusting for age, gender, and baseline EQ-
5D-5L index score [61]. To assess uncertainty surround-
ing the estimates and to account for the typically skewed
nature of cost data, incremental costs and QALYs were
bootstrapped using pairwise bootstrapping with replace-
ment using 10,000 replications. Cost-effectiveness planes
plot these 10,000 bootstrap replications of the ICER
estimates to illustrate the uncertainty around the point
estimate of the ICER in probabilistic terms. Finally, cost-
effectiveness acceptability curves (CEACs) were plotted
to graphically represent the probability of the interven-
tion being cost-effective across a range of cost-
effectiveness thresholds.
The primary economic analysis was based on a
comparison on the full sample with MI. A sensitivity
analysis was performed using only the complete case
sample for which there were no missing data. We
also took advantage of the implementation delays to
perform a further sensitivity analysis separating the
trial period into two parts: baseline to 6 months
follow-up, where no treatment had yet been received;
and 6 months to 20 months follow-up, where we ex-
pect any treatment effects to occur. Stata version 14
was used in the analysis.
Results
Recruitment, retention and baseline characteristics
In total, 12,989 patients were identified as eligible for
the cohort, and at baseline 4377 (33.6%) participated. Of
those, 1306 were eligible for PROTECTS. Of the 1306,
504 were randomly selected to the intervention, and the
remaining 802 eligible participants acted as controls.
The flow of participants is shown in Fig. 1. The baseline
characteristics of participants are presented in Table 1.
Treatment uptake and adherence
Signed consent to health coaching amongst those eli-
gible was received from 207/504 (41%) of those selected,
although only 189 actually received calls (38%). The
baseline characteristics of consenters and non-
consenters are reported in Additional file 3: Table A. A
multivariate logistic regression exploring baseline factors
associated with consent found that only younger age
(odds ratio (OR) = 1.08, 95% confidence interval (CI) = 1.
03–1.14) and higher education (OR = 4.07, 95% CI = 2.
08–7.94) predicted consent to health coaching.
Among those who consented, 167/189 (85%) re-
ceived 4+ calls (the predefined ‘dose’). Assessment of
call content showed that diet and exercise were the
most common areas dealt with (in 70% and 57% of
patients respectively), whereas 25% of patients re-
ceived social prescribing and around 23% received
support for low mood.
Outcomes
Table 2 shows the patient-reported outcomes for pa-
tients selected for the offer of health coaching and those
not selected. The adjusted mean differences were small
for all of the primary and secondary outcome measures
and did not reach statistical significance (p > 0.05). The
non-significance of all group differences was confirmed
in both sensitivity analyses.
Using CACE analysis, the estimated treatment effects
on participants who took up the intervention were
higher, but with correspondingly wider non-significant
confidence intervals (Table 2).
Economic analysis
Complete data necessary for the economic analysis were
available for 45% of the sample (584/1306).
Table 3 shows EQ-5D-5L utility scores at each time
point and the total QALY gain over 18 months for the
complete case sample. Patients selected for the offer of
health coaching reported slightly lower EQ-5D-5L scores
at baseline. This steadily fell at each time point for the
usual care group (0.664 at 18 months follow-up), whilst
remaining stable for the health coaching group (0.691).
The mean unadjusted QALYs for usual care were 1.105,
and 1.124 for health coaching over the study period.
The resources required to deliver the health coaching
intervention are presented in Additional file 3: Table B.
The average cost per individual receiving the full course
of health coaching (6 calls) was £148.27. In addition to
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the direct costs, the analysis also considered the wider
NHS resource utilisation. Table 4 reports the average
utilisation by resource category for the complete case
sample. Overall, there was a pattern of greater use of
emergency care amongst the control group, whilst the
group offered health coaching used more planned
services.
Table 5 presents the average costs of the resource util-
isation of the complete case sample. The list of unit
costs and resources is available in Additional file 3: Table
C. The most costly category was outpatient appoint-
ments, followed by elective admissions and GP appoint-
ments. These are all planned care services, the costs of
which were higher in the health coaching group. Con-
versely, the costs of emergency admissions (short and
long stays), day cases, and A&E attendances were higher
in usual care. Overall, mean costs were higher in health
coaching (£4000.88) than usual care (£3424.16). The
average intervention costs in health coaching were £79.
29. This is lower than the £148.27 estimated for a course
of health coaching because not all individuals took up or
completed the health coaching.
Cost-effectiveness analysis: full sample with imputation
Table 6 presents the adjusted estimates of the effects of
the offer of health coaching on the incremental costs
and QALYs compared to usual care in the full sample
with imputed data, controlling for age, gender and base-
line utility.
Fig. 1 PROTECTS CONSORT diagram
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The offer of health coaching is associated with a mean
incremental total cost increase of £150.58 (95% CI £–
470.611, £711.776) and a mean incremental QALY gain
of 0.019 (95% CI –0.006, 0.043).
Whilst there are no statistically significant differ-
ences in either costs or QALYs, the point estimate of
the ICER is £8049.96 per QALY. This would repre-
sent a cost-effective intervention at the standard cost-
per-QALY threshold of £20,000–30,000. However, it is
important to consider the uncertainty surrounding
this estimate. The cost-effectiveness plane plots the
10,000 bootstrap replications of incremental cost and
QALY estimates (Fig. 2). The replications are clus-
tered in the north-east quadrant in Fig. 2 (positive
health gain and increased cost). Health coaching re-
sulted in an incremental QALY gain in 94% of boot-
strap replications and was higher cost in 69% of
replications.
Table 1 Baseline characteristics of participants
Characteristics Not selected (n = 802) Selected (n = 504) Total (n = 1306)
Mean (SD) age 74.2 (6.4) 75.4 (6.8) 74.7 (6.6)
Age in categories:
65–69 years 216 (26.9) 115 (22.8) 331 (25.3)
70–79 years 385 (48.0) 230 (45.6) 615 (47.1)
80–98 years 155 (19.3) 140 (27.8) 295 (22.6)
Sex (%):
Female 441 (55.0) 270 (53.6) 711 (54.4)
Male 357 (44.5) 232 (46.0) 589 (45.1)
Health literacy:
Never 536 (66.8) 322 (63.9) 858 (65.7)
Rarely 100 (12.5) 57 (11.3) 157 (12.0)
Sometimes 87 (10.9) 63 (12.5) 150 (11.5)
Often/always 59 (7.4) 44 (8.7) 103 (7.9)
Living status (%):
Live with partner or others 509 (63.5) 315 (62.5) 824 (63.1)
Live alone 288 (35.9) 188 (37.3) 476 (36.5)
Education (%):
No qualifications 352 (43.9) 221 (43.9) 573 (43.9)
School level qualifications 68 (8.5) 56 (11.1) 124 (9.5)
College degree or higher 349 (43.5) 191 (37.9) 540 (41.4)
Mean (SD) chronic conditions 6.8 (2.6) 6.8 (2.5) 6.8 (2.6)
Mean (SD) index of multiple deprivation 31.0 (18.8) 33.0 (18.6) 31.8 (18.7)
Employment (%):
Retired or not economically active 748 (93.3) 472 (93.7) 1220 (93.4)
Working or other 39 (4.7) 23 (4.6) 62 (4.8)
Ethnicity (%):
White 786 (98.0) 489 (97.0) 1275 (97.6)
Non-white 11 (1.37) 12 (2.4) 23 (1.8)
Mean (SD) GP visits in past 6 months 3.1 (2.0) 3.0 (1.9) 3.1 (1.9)
Mean (SD) patient activation 57.8 (6.0) 57.6 (5.6) 57.8 (5.9)
Mean (SD) quality of life (physical health) 55.3 (19.8) 54.0 (18.8) 54.8 (19.4)
Mean (SD) depressive symptoms 65.3 (21.3) 65.3 (21.8) 65.3 (21.3)
Possible depression diagnosis (%):
Depression 371 (46.3) 227 (45.0) 598 (45.8)
No depression 426 (53.1) 265 (52.9) 691 (52.9)
Mean (SD) self-care activities 3.8 (0.9) 3.8 (0.9) 3.8 (0.9)
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The CEAC (Fig. 3) demonstrates how the probabil-
ity that health coaching is cost-effective increases
with the decision-maker’s willingness to pay. At the
lower bound threshold of £20,000 per QALY, there
is a 70% probability of health coaching being cost-
effective. This rises to 79% at the upper bound of
£30,000. Compared with usual care, health coaching
is likely to be cost-effective in 50% or more cases if
decision-makers are willing to pay £8180 or more
for a QALY.
The results of the cost-effectiveness analyses were
similar when a complete case analysis was undertaken
(see Additional file 4). The post hoc sensitivity ana-
lysis analysing costs and outcomes separately in the
first 6 months post baseline (when no health coaching
was received) confirmed that the period in which
participants actually received treatment was driving
outcomes, as the effects were restricted to the period
in which health coaching was delivered (see Figures C
to F in Additional file 4).
Discussion
Principal outcomes
We evaluated the role of health coaching in the care of
multimorbidity. We showed reasonable levels of interven-
tion uptake amongst older patients with multimorbidity
who were not actively seeking help with self-management.
A large proportion of those who accepted the referral to
health coaching received a defined ‘dose’. Assistance with
diet and exercise were the most common interventions
within health coaching, although support for low mood
and social prescribing were also present for a significant
minority.
Analysis of health outcomes demonstrated no signifi-
cant benefit associated with health coaching. However,
the economic analysis suggested that health coaching
resulted in an incremental increase in both costs and
QALYs. When a QALY was valued at £20,000, there was
a 70% probability that health coaching was cost-effective.
The economic analysis suggested that health coaching
led to higher utilisation of planned services and lower
use of emergency hospital services than usual care.
Strengths and limitations
In addition to its large size and focus on multimorbidity,
this trial employed the novel ‘Trials within Cohorts’ de-
sign. This design provides evidence of ‘reach’ because it
assesses uptake amongst people not actively seeking treat-
ment. A major criticism of conventional trials is that they
show effectiveness of an innovation in a very selected
group of patients, which then fails to ‘scale’ because of is-
sues such as low rates of acceptability amongst the wider
population, and differences between those who take part
in trials and those eligible for the intervention [11].
Table 2 Intention-to-treat analyses of primary and secondary outcomes, using complete cases
Intervention group
(eligible patients selected
for treatment)
Control group
(eligible patients not
selected for treatment)
Comparison CACE estimates
(estimated points change
in those consenting
to treatment)
N Mean (SD) N Mean (SD) Adjusted
difference
p value Adjusted difference in
meansa (95% CI)
in meansa (95%
CI)
Primary outcomes
Patient Activation Measure (PAM) 326 62.88 (14.39) 577 61.92 (13.24) 1.44
(−0.46 to 3.33)
0.133 3.69 (−1.17 to 8.53)
WHO Quality of Life —- physical health
(WHOQOL)
327 55.74 (19.15) 577 55.41 (18.72) 1.62
(−0.32 to 3.56)
0.099 4.15 (−0.82 to 9.12)
Secondary outcomes
Depression (Mental Health Inventory,
MHI-5)
325 75.74 (16.40) 583 74.29 (17.26) 1.00
(−1.25 to 3.26)
0.373 2.56 (−3.20 to 8.36)
Self-care (SDSCA) 321 3.49 (1.09) 572 3.54 (1.10) −0.04
(−0.19 to 0.11)
0.58 −0.10 (−0.49 to 0.28)
aAdjusted for covariates gender, age, health literacy, social support, patient activation, depression and quality of life
Table 3 HRQOL outcomes (EQ-5D-5L) amongst the complete
case sample
Usual care (n = 378) Health coaching (n = 206)
Mean SD Min Max Mean SD Min Max
Baseline 0.708 0.23 −0.18 1 0.696 0.236 −0.102 1
6 months 0.691 0.247 −0.185 1 0.709 0.228 0.018 1
12 months 0.685 0.254 −0.246 1 0.694 0.237 0 1
18 months 0.664 0.264 −0.18 1 0.691 0.26 0 1
QALYs 1.105 0.374 −0.29 1.723 1.124 0.355 0.055 1.683
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Table 4 Resource utilisation amongst the complete case sample
Baseline to 6 months
Type of service Usual care (n = 378) Health coaching (n = 206)
Mean (95% CI) Mean (95% CI)
Secondary care contacts
Emergency short stay 0.063 (0.039—0.088) 0.058 (0.026–0.091)
Emergency long stay 0.026 (0.009–0.044) 0.024 (0.003–0.045)
Day case 0.172 (0.104–0.240) 0.112 (0.059–0.165)
Elective admission 0.024 (0.008–0.039) 0.029 (0.002–0.056)
Outpatient 4.992 (4.162–5.823) 6.553 (4.977–8.130)
A&E attendance 0.156 (0.110–0.203) 0.131 (0.083–0.179)
GP appointments 3.111 (2.791–3.431) 3.039 (2.641–3.437)
6 months to 12 months
Secondary care contacts Mean (95% CI) Mean (95% CI)
Emergency short stay 0.050 (0.027–0.074) 0.039 (0.006–0.072)
Emergency long stay 0.040 (0.010–0.069) 0.019 (0.000–0.038)
Day case 0.127 (0.069–0.185) 0.053 (0.017–0.090)
Elective admission 0.029 (0.009–0.049) 0.029 (0.002–0.056)
Outpatient 4.595 (3.650–5.540) 6.403 (5.126–7.680)
A&E attendance 0.159 (0.108–0.209) 0.097 (0.041–0.153)
GP appointments 2.783 (2.527–3.039) 3.058 (2.696–3.421)
12 months to 18 months
Secondary care contacts Mean (95% CI) Mean (95% CI)
Emergency short stay 0.132 (0.091–0.174) 0.068 (0.028–0.108)
Emergency long stay 0.045 (0.022–0.068) 0.034 (0.009–0.059)
Day case 0.196 (0.107–0.284) 0.180 (0.105–0.254)
Elective admission 0.040 (0.020–0.059) 0.063 (0.027–0.099)
Outpatient 7.185 (6.064–8.307) 9.893 (8.570–11.217)
A&E attendance 0.275 (0.207–0.343) 0.170 (0.112–0.228)
GP appointments 2.865 (2.599–3.131) 2.922 (2.543–3.302)
Table 5 Resource use costs amongst the complete case sample
Type of service Usual care (n = 378) Health coaching (n = 206)
Mean (£)
95% CI
Mean (£)
95% CI
Secondary care costs
Emergency short stay 146.87 (112.25–181.48) 98.95 (64.27–133.63)
Emergency long stay 313.76 (190.97–436.54) 219.08 (101.92–336.24)
Day case 343.61 (212.29–474.93) 238.36 (166.87–309.86)
Elective admission 310.71 (203.04–418.38) 405.96 (201.93–609.99)
Outpatient appointment 1851.42 (1605.13–2097.70) 2521.95 (2139.57–2904.32)
A&E attendance 76.66 (62.69–90.63) 51.79 (39.33–64.24)
Mean total costs of secondary care contacts 3043.02 (2626.02–3460.03) 3536.09 (2979.87–4092.31)
GP appointments 381.14 (350.96–411.32) 392.50 (351.72–433.28)
Health coaching costs – 79.29 (69.59–88.99)
Mean total cost 3424.16 (2999.98–3848.34) 4007.88 (3444.57–4571.18)
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However, this trial also has important limitations,
some of which are directly associated with the TWiCs
design. A conventional pragmatic trial assesses inter-
vention effects on those consenting to treatment, with
an assumption that there will be non-adherence
amongst consenters which will reduce any interven-
tion effect (as these are included in any intention-to-
treat analysis). The current design estimates the mean
effect of selection for treatment, and again all patients
selected for treatment must remain in that group in
the intention-to-treat analysis. The proportion of
selected patients who do not take up the intervention
in a ‘trial within a cohort’ will likely always be larger
than the proportion of consenting patients who do
not comply with treatment in a conventional prag-
matic trial. In consequence, the inclusion in the PRO-
TECTS treatment group of 59% of participants
selected for the intervention who did not take it up
— including 10% who were uncontactable — greatly
diluted the overall treatment effect compared to con-
trols, and resulted in a detectable standardised effect
(amongst those consenting to treatment) of 0.39,
rather than the 0.25 initially powered for. We have
since published specific methods for estimating sam-
ple sizes for this type of design [47].
Our ability to detect an effect is likely to have been
further reduced by the use of data collected at fixed time
intervals, as start of treatment varied greatly relative to
the collection of baseline measures — with correspond-
ingly wide variation between end of treatment and
20 months follow-up. The logistics of the research and
capacity within the service meant that no participant
was offered the intervention prior to the 6 months
follow-up. Changes in health or behaviours over this
period may have an impact on the effectiveness of an
intervention, possibly reducing differences between
groups. Nevertheless, delays in accessing treatment are
common in routine service delivery. Another ‘trial
within a cohort’ (the Depression in South Yorkshire
(DEPSY) trial) achieved a somewhat higher consent rate
of 51%, but with 19% of those selected uncontactable
[62]. DEPSY experienced a much higher attrition rate in
the treatment arm, 32% compared to 13% of controls,
and we found some evidence for differential attrition.
These and other TWiCs design-related issues are con-
sidered in a related publication [47].
The trial cannot answer the question of whether health
coaching is effective and cost-effective for multimorbid-
ity in the longer term. The health coaching intervention
consisted of three mechanisms, but the design does not
allow us to estimate their distinct contribution. Nearly
half of the patients reported symptoms of depression,
and although support for low mood was provided fre-
quently, it may have to be a more significant aspect of
interventions in patients with multimorbidity [63]. The
economic analysis was based on 45% of patients who
Table 6 Cost-effectiveness analysis: full sample with imputation
Health coaching (n = 504) over usual care (n = 802) Mean Bootstrapped standard error Bootstrapped 95% CI
Incremental cost (£) 150.583 316.941 −470.611 771.776
Incremental QALYs 0.019 0.012 −0.006 0.043
ICER £8049.96
Fig. 2 Cost-effectiveness plane: full sample with imputed data
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returned complete data, which may limit the general
conclusions. Although multiple imputation was used to
impute missing data values, this cannot fully adjust for
unmeasured factors that may affect both outcomes and
questionnaire completion; hence, the cost-effectiveness
findings may be subject to residual confounding. How-
ever, a sensitivity analysis comparing cost-effectiveness
in the 6 months prior to the intervention — in which
time the majority of attrition occurred — with cost-
effectiveness under the intervention found the effects
restricted to the latter period.
Finally, this trial was conducted amongst patients with mul-
timorbidity in one area in the UK primarily composed of
white patients. Ethnic minority groups report poorer experi-
ence of care [64], and we do not know whether the effective-
ness, reach and cost-effectiveness of health coaching are
different in ethnic minority groups with multimorbidity.
Although we have described this as a population health
approach, we did restrict to certain groups depending on
baseline activation, so ‘reach’ was somewhat limited by design.
The response rate of patients to the initial cohort recruitment
was in line with previous studies in this area [65, 66], but is
potentially another source of bias, and with very limited
demographic data on non-responders to the initial cohort, we
were unable to assess overall representativeness. Although
patient inclusion in the cohort was based on data within clin-
ical records, patients self-reported types of long-term condi-
tions, and these were not validated against clinical diagnosis.
Interpretation of the results in the context of the wider
literature
It was felt that this design was a relevant test of health
coaching as a population health strategy, reaching out to
patients assessed as in need, but who may not necessar-
ily be seeking self-management support. There will nat-
urally be interest in the effects on those patients who
engaged. Although per-protocol analyses can be used,
such an approach is vulnerable to bias. Some published
trials have assessed the effects through propensity
matching of the subset who engaged [67]. The CACE
analysis is the preferred model for assessment of effects
in those who receive the intervention, as under certain,
though usually reasonable, assumptions it provides an
unbiased estimate of effect.
Further development of the intervention may have to
consider different approaches to targeting, or more
choice around the exact nature of the intervention to
better align with patient preferences. Qualitative re-
search conducted alongside the trial will be published
in the full study report and may provide insights into
these issues [68]. The group entering the trial did
report significant numbers of conditions, and it is pos-
sible that they were too ill to benefit from the interven-
tion. As noted earlier, existing treatment burden may
be high in these patients, and although the coaching is
designed to support self-management, it is possible that
adding more self-management may exacerbate issues in
treatment burden [69]. Our model of using activation
to target the intervention is in line with the suggested
uses of the measure [21] and reflects previous health
coaching studies which have suggested the importance
of avoiding patients who are too ill or too well to bene-
fit [70]. There is good evidence that activation predicts
many outcomes, but the evidence that activation can
predict differential benefit from interventions is not as
strong [34].
Fig. 3 Cost-effectiveness acceptability curve: full sample with imputed data
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The pattern of health utilisation shown in the different
groups is of interest. Many interventions for older
people target those who demonstrate high levels of
health care utilisation, on the basis that this is where
reductions are most likely to be made. Nevertheless, it
can be difficult to reduce utilisation in such patients in a
comparative study [19], as patients identified on the
basis of high use may demonstrate regression to the
mean, may not be particularly amenable to intervention
and may be present in small numbers in the population
[20]. One of the largest trials of health coaching under-
taken used a risk prediction score for inclusion in the
trial, but it failed to demonstrate overall benefits in
terms of admission rates [67]. The approach taken in
PROTECTS was different, as patients were identified on
the basis of showing capacity for improvement in activa-
tion. Such patients are prevalent, and the results sug-
gested that the intervention might reduce emergency
use of care. However, the positive impacts of such
change were ameliorated by increases in elective use
and overall increases in costs. Another very large trial
of health coaching which showed reductions in costs
had an additional focus on ‘preference sensitive’
shared decision-making rather than self-management
alone [70].
As noted earlier, the recent Cochrane review reported
only limited evidence for patients with multimorbidity
[8], although there was a suggestion that interventions
targeted at risk factors such as depression or specific
functional difficulties might be more effective. Whilst
our intervention had a depression component, it was
not the primary focus as in other interventions in multi-
morbidity [63], and it is possible that the broad focus on
self-management behaviour change is less impactful than
a specific focus on a single area such as depression,
especially in the context of an intervention of limited
duration. Alternatively, our focus on depression may
have paid insufficient attention to other psychosocial is-
sues that might be present in these patients, such as
anxiety or functional disorders. It is equally possible that
for patients with fairly high levels of multimorbidity, the
dose of the coaching was simply insufficient [67]. A lon-
ger treatment might have increased effectiveness,
although with restricted resources, increasing the length
of treatment will clearly restrict ‘reach’.
Conclusions
Patients with multimorbidity are a major part of the
workload of health systems, and findings from large
evaluations of new models of care for this patient group
are directly relevant to clinicians and policy decision-
makers. The interpretation of the results will depend on
the relative weight placed by decision-makers on clinical
and economic outcomes. To readers focussed on clinical
outcomes, the trial demonstrated that health coaching
led to no changes in activation or quality of life. How-
ever, the economic analyses showed that the intervention
was likely to represent a cost-effective use of resources
at conventional levels of willingness to pay. The eco-
nomic analysis examines the effect of health coaching
using a generic measure of health-related quality of life,
which may detect broader impacts of the intervention
not captured by the primary trial outcomes. It also con-
siders the trade-off between differences in costs and ef-
fects associated with the intervention.
Decision-makers may not be convinced of the benefits
of health coaching in the absence of evidence of clinical
improvement. However, resource utilisation patterns
highlighted interesting results which warrant further in-
vestigation. Individuals offered health coaching had
higher utilisation of planned services and lower use of
emergency hospital services. Health coaching may have
had a positive impact by increasing individuals’ wider
engagement in the health service. Due to the limited
follow-up period of the trial, we are not able to assess
whether such increased engagement with planned ser-
vices is maintained.
Health coaching in patients with multimorbidity did
not lead to significant benefits on the primary measures
of patient-reported outcome. The optimal role of this
model of care within integrated care systems for patients
with multiple long-term conditions remains unclear.
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